智通财经APP获悉，石四药集团(02005)午后跌近9%，截至发稿，跌8.99%，报3.14港元，成交额4928.28万港元。
消息面上，石四药集团午间发布2024年度业绩，集团收益57.73亿港元，同比减少10.67%；同期毛利率50.4%，同比下降5.6个百分点；股东应占溢利10.61亿港元，同比减少19.53%；每股基本盈利0.3582港元；拟派末期息每股0.095港元。
分业务看，2024年，集团输液整体累计实现销售量20.36亿瓶(袋)，同比增长6.7%，销售额37.35亿港元，同比减少7.6%，主要原因是受政策性和市场性叠加因素影响，基础输液存量市场需求乏力、价格下滑，增长不及预期。口服制剂产品销售收入达约5.02亿港元，同比增长约4.9%。原料药实现销售额约7.85亿港元，同比减少11.7%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.